<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="218355">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00241995</url>
  </required_header>
  <id_info>
    <org_study_id>RCT-RCT_LOND_GAT_AWS_2003</org_study_id>
    <nct_id>NCT00241995</nct_id>
  </id_info>
  <brief_title>Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <brief_summary>
    <textblock>
      The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate,
      lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind</masking>
  </study_design_info>
  <condition>Topiramate</condition>
  <condition>Lamotrigine</condition>
  <condition>Memnatine</condition>
  <condition>Diazepam</condition>
  <condition>Placebo</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anticonvulsants</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Alcohol dependence Alcohol withdrawal syndrome

        Exclusion Criteria:

        Drug dependence Major psychiatric diagnoses Severe somatic illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgeny M Krupitsky, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Petersburg State Pavlov Medical University</affiliation>
  </overall_official>
  <verification_date>October 2005</verification_date>
  <lastchanged_date>October 17, 2006</lastchanged_date>
  <firstreceived_date>October 17, 2005</firstreceived_date>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
